Enwei Pharmaceutical Co (SZSE:301331) Total Liabilities : ¥276.0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Enwei Pharmaceutical Co Total Liabilities?

Enwei Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥276.0 Mil.

Enwei Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2023 (¥204.71 Mil) to Dec. 2023 (¥234.31 Mil) and increased from Dec. 2023 (¥234.31 Mil) to Mar. 2024 (¥275.99 Mil).

Enwei Pharmaceutical Co's annual Total Liabilities increased from Dec. 2021 (¥226.84 Mil) to Dec. 2022 (¥253.08 Mil) but then declined from Dec. 2022 (¥253.08 Mil) to Dec. 2023 (¥234.31 Mil).

Enwei Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Enwei Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enwei Pharmaceutical Co Total Liabilities Chart

Enwei Pharmaceutical Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

263.66

262.34

226.84

253.08

234.31

Enwei Pharmaceutical Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial														251.00	227.04	204.71	234.31	275.99

Enwei Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Enwei Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	209.773	+	(0.455	+	24.084
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	234.3

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1337.498	-	1103.186
	=	234.3

Enwei Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	219.166	+	(33	+	23.819
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	276.0

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1355.537	-	1079.552
	=	276.0

Enwei Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Enwei Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Enwei Pharmaceutical Co (SZSE:301331) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enwei Pharmaceutical Co Ltd (SZSE:301331) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Chuangye Avenue, Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region, Changdu, CHN, 854000

Website

http://www.enwei.com.cn

Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.

Enwei Pharmaceutical Co (SZSE:301331) Headlines

No Headlines